AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...

Targeting European allies won't fix any of our problems with China, or improve health care, writes Josh Steuterman.

President Donald Trump has threatened tariffs on drugs coming from overseas, but it might take more than that to reroute the ...

President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the industries in the firing line.

Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.

U.S. tariff revenues hit a record $100 billion, but most new tariffs haven't taken effect yet, signaling more economic ...

U.S. tariffs of 30% on European Union goods could shave up to 0.8% off Italy's gross domestic product in 2027, the country's ...